Open AccessInitial steroid-free immunosuppression after liver transplantation in recipients with hepatitis c virus related cirrhosis
Author(s) -
Perdita WietzkeBraun,
Felix Braun,
Burckhart Sattler,
Giuliano Ramadori,
Burckhardt Ringe
Publication year - 2004
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v10.i15.2213
Subject(s) - immunosuppression , medicine , cirrhosis , liver transplantation , tacrolimus , hepatitis c virus , gastroenterology , hepatitis c , transplantation , immunology , virus
Steroids can increase hepatitis C virus (HCV) replication. After liver transplantation (LTx), steroids are commonly used for immunosuppression and acute rejection is usually treated by high steroid dosages. Steroids can worsen the outcome of recurrent HCV infection. Therefore, we evaluated the outcome of HCV infected liver recipients receiving initial steroid-free immunosuppression.